JustCo, Frasers Property and Daito Trust have all put their weight behind the property technology startup hub, founded by a former WeWork China executive.
Month: November 2020
Hacarus hacks series B funding
MTG Ventures and Ohara Pharmaceutical backed the second close of the medical data modelling technology developer’s latest round, which stands at $12.4m.
Plaid pushes towards IPO
The customer data analytics software operator is scheduled to go public on TSE Mothers Market, allowing Google, Mitsui and Mitsui Sumitomo Insurance to exit.
Unilabo unites corporates for series B round
Japan Post Capital co-led a $13.8m round for the B2B subcontracting service that included Hakuhodo DY Ventures, Mitsubishi UFJ Capital, SBI Investment and UB Ventures.
Yappli gets IPO application approved
The mobile app development platform is set to float on TSE’s Mothers Market in an initial public offering that would allow Globis, Itochu, Salesforce and Yahoo Japan to exit.
Powerlist Q&A – Suzanna Chiu, Amadeus Ventures
Q&A with Suzanna Chiu, head, Amadeus Ventures
Headhunters’ dream team
The first rule of management is avoiding demotivating people.
Airbnb aims for $1bn in IPO
CapitalG-backed short-term accommodation provider Airbnb last raised financing at a $1bn pre-money valuation in April.
PingCap taps Bertelsmann in $270m series D
Bertelsmann Asia Investments contributed to a round that the distributed database developer will use for global growth and research and development.
Gojek sells Telkomsel on $150m investment
The mobile network operator has joined a pool of corporate investors in ride hailing service and strategic partner Gojek.
Zomato stows away $195m
The food delivery platform developer, backed by Info Edge, Ant Financial, Uber and Delivery Hero, is now valued at $3.6bn.
Sigilon signals $100m IPO target
Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.
BioAtla bids for public markets spot
Pfizer Ventures is the largest individual shareholder in the cancer therapeutics developer, which has filed for a $100m offering.
Sanofi sends $59m to Jeito Capital
The biotech investment firm is the first external life sciences investor to get a fund commitment from pharmaceutical company Sanofi.